The University of Chicago Header Logo

Connection

Jeffrey Hubbell to Lymphocyte Activation

This is a "connection" page, showing publications Jeffrey Hubbell has written about Lymphocyte Activation.
Connection Strength

0.401
  1. Cysteine-binding adjuvant enhances survival and promotes immune function in a murine model of acute myeloid leukemia. Blood Adv. 2024 Apr 09; 8(7):1747-1759.
    View in: PubMed
    Score: 0.190
  2. Lymph Node-Targeted Synthetically Glycosylated Antigen Leads to Antigen-Specific Immunological Tolerance. Front Immunol. 2021; 12:714842.
    View in: PubMed
    Score: 0.159
  3. Vaccine nanocarriers: Coupling intracellular pathways and cellular biodistribution to control CD4 vs CD8 T cell responses. Biomaterials. 2017 07; 132:48-58.
    View in: PubMed
    Score: 0.029
  4. Targeting the tumor-draining lymph node with adjuvanted nanoparticles reshapes the anti-tumor immune response. Biomaterials. 2014 Jan; 35(2):814-24.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.